Elaine Hyshka Publications

Select publications

2024

Haines-Saah RJ, Morris H, Schulz P, Jenkins E, Hyshka E. (2024). Engaging families and parent advocates in research on substance use and drug policy reform: Guiding principles from a Canadian community-academic partnership. Drug Alcohol Rev. 43(5):1045-1048.
Wilson P, Colizza K, Hyshka E. (2024). Safer supply and political interference in medical practice: Alberta’s Narcotics Transition Services. Int J Drug Policy. 133:104600.
Ali F, Russell C, Lo M, Bonn M, Bardwell G, Boyd J, Hyshka E, Rehm J. (2024). Unpacking the Effects of Decriminalization: Understanding Drug Use Experiences and Risks among Individuals Who Use Drugs in British Columbia. Harm Reduct J. 21(1):190.
Curtin KD, Thomson M, Hyshka E, Colman I, Wild TC, Belon AP, Nykiforuk CIJ. (2024). Assessing support for substance use policies among the general public and policy influencers in two Canadian provinces. Subst Abuse Treat Prev Policy. 4;19(1):40.
Dubois C, Fernandes H, Lin M, Martins KJB, Dyck JRB, Klarenbach SW, Richer L, Jess E, Hanlon JG, Hyshka E, Eurich DT. (2024). Benzodiazepine use in medical cannabis authorization adult patients from 2013 to 2021: Alberta, Canada. BMC Public Health. 24(1):859.
Hyshka E, Moore DM, Knight R, Neudorf C, Urbanoski K. (2024). The need for an expanded, evidence-based public health response to the overdose crisis and the toxic drug supply in Canada. Can J Public Health. 115(2):181-185.
Cattell C, Hyshka E, Leier B, Mack C. (2024). Capacity, Rationality, and the Promotion of Autonomy: A Trauma-Informed Approach to Refusals of Care After Opioid Poisoning. Am J Bioeth. 24(5):48-51.
Englander H, Thakrar AP, Bagley SM, Rolley T, Dong K, Hyshka E. (2024). Caring for Hospitalized Adults With Opioid Use Disorder in the Era of Fentanyl: A Review. JAMA Intern Med. 184(6):691-701.
Nykiforuk CIJ, Thomson M, Curtin KD, Colman I, Wild TC, Hyshka E. (2024). Assessing support for mental health policies among policy influencers and the general public in Alberta and Manitoba, Canada. Int J Ment Health Syst. 18(1):8.
Brooks HL, Speed KA, Dong K, Salvalaggio G, Pauly BB, Taylor M, Hyshka E. (2024). Perspectives of patients who inject drugs on a needle and syringe program at a large acute care hospital. PLoS One. 19(2):e0297584.
Dubois C, Lunghi C, Eurich DT, Dyck JRB, Hyshka E, Hanlon JG, Zongo A. (2024). Medical cannabis authorization and risk of emergency department visits and hospitalization due to psychotic disorders: A propensity score-matched cohort study. Schizophr Res. 264:534-542.

2023

Morris H, Wild TC, Giovannoni M, Haines-Saah R, Koziel J, Schulz P, Bwala H, Kunyk D, Bubela T, Hyshka E. (2023). Canadian newspaper coverage on harm reduction featuring bereaved mothers: A mixed methods analysis. PLoS One. 18(11):e0294608.
Salvalaggio G, Brooks H, Caine V, Gagnon M, Godley J, Houston S, Kennedy MC, Kosteniuk B, Livingston J, Saah R, Speed K, Urbanoski K, Werb D, Hyshka E. (2023). Flawed reports can harm: the case of supervised consumption services in Alberta. Can J Public Health. 114(6):928-933.
Haines-Saah RJ, Morris H, Schulz P, Jenkins E, Hyshka E. (2023). Engaging families and parent advocates in research on substance use and drug policy reform: Guiding principles from a Canadian community-academic partnership. Drug Alcohol Rev.
Karamouzian M, Rafat B, Kolla G, Urbanoski K, Atkinson K, Bardwell G, Bonn M, Touesnard N, Henderson N, Bowles J, Boyd J, Brunelle C, Eeuwes J, Fikowski J, Gomes T, Guta A, Hyshka E, Ivsins A, Kennedy MC, Laurence G, Martignetti L, Nafeh F, Salters K, Tu D, Strike C, Pauly B, Werb D. (2023). Challenges of implementing safer supply programs in Canada during the COVID-19 pandemic: A qualitative analysis. Int J Drug Policy. 120:104157.
Galarneau LR, Speed K, Taylor M, Hyshka E. (2023). Operating an overdose prevention site within a temporary emergency shelter during the COVID-19 pandemic. Can J Public Health. 114(5):787-795.
Nykiforuk CIJ, Belon AP, de Leeuw E, Harris P, Allen-Scott L, Atkey K, Glenn NM, Hyshka E, Jaques K, Kongats K, Montesanti S, Nieuwendyk LM, Pabayo R, Springett J, Yashadhana A. (2023). An action-oriented public health framework to reduce financial strain and promote financial wellbeing in high-income countries. Int J Equity Health. 22(1):66.
Nykiforuk CI, Belon AP, de Leeuw E, Harris P, Allen-Scott L, Atkey K, Glenn NM, Hyshka E, Jaques K, Kongats K, Montesanti S, Nieuwendyk LM, Pabayo R, Springett J, Yashadhana A. (2023). A Policy-Ready Public Health Guidebook of Strategies and Indicators to Promote Financial Well-Being and Address Financial Strain in Response to COVID-19. Prev Chronic Dis. 20:E09.
Wiese JL, Watson TM, Owusu-Bempah A, Hyshka E, Wells S, Robinson M, Elton-Marshall T, Rueda S. (2023). Overpoliced and Underrepresented: Perspectives on Cannabis Legalization From Members of Racialized Communities in Canada. Contemp Drug Probl. 50(1):25-45.
Morris H, Bwala H, Wesley J, Hyshka E. (2023). Public support for safer supply programs: analysis of a cross-sectional survey of Canadians in two provinces. Can J Public Health. 114(3):484-492.

2022

Salvalaggio G, Hyshka E, Brown C, Pinto AD, Halas G, Green L, Kosteniuk B, Perri M, Le Chalifoux N, Halas G, Steiner L, Cavett T, Montesanti S. (2022). A comparison of the COVID-19 response for urban underserved patients experiencing healthcare transitions in three Canadian cities. Can J Public Health. 113(6):846-866.
Zongo A, Lee C, Dyck JRB, El-Mourad J, Hyshka E, Hanlon JG, Eurich DT. (2022). Incidence and Predictors of Cannabis-Related Poisoning and Mental and Behavioral Disorders among Patients with Medical Cannabis Authorization: A Cohort Study. Subst Use Misuse. 57(10):1633-1641.
Gehring ND, Speed KA, Dong K, Pauly B, Salvalaggio G, Hyshka E. (2022). Social service providers’ perspectives on caring for structurally vulnerable hospital patients who use drugs: a qualitative study. BMC Health Serv Res. 22(1):1138.
Kosteniuk B, Speed K, Candler E, Campbell S, Penney G, Moen K, Hyshka E. (2022). Public health approaches to substance use: a scoping review protocol. JBI Evid Synth. 1;20(9):2395-2407.
Zolopa C, Brothers TD, Leclerc P, Mary JF, Morissette C, Bruneau J, Hyshka E, Martin NK, Larney S. (2022). Changes in supervised consumption site use and emergency interventions in Montréal, Canada in the first twelve months of the COVID-19 pandemic: An interrupted time series study. Int J Drug Policy. 110:103894.
Benny C, Smith BT, Hyshka E, Senthilselvan A, Veugelers PJ, Pabayo R. (2022). Investigating the association between income inequality in youth and deaths of despair in Canada: a population-based cohort study from 2006 to 2019. J Epidemiol Community Health. 2022 Nov 2:jech-2022-219630.
Rudzinski K, Chan Carusone S, Ceranto A, Ibáñez-Carrasco F, McDonald L, Valentine D, Guta A, Hyshka E, O’Leary W, Cardow A, Strike C. (2023). Philanthropic donor perspectives about providing harm reduction services for people living with HIV/AIDS in a hospital setting. Harm Reduct J. 19(1):124.
Brooks HL, Salvalaggio G, Pauly B, Dong K, Bubela T, Taylor M, Hyshka E. (2022). “I have such a hard time hitting myself, I thought it’d be easier”: perspectives of hospitalized patients on injecting drugs into vascular access devices. Harm Reduct J. 19(1):54.
Salvalaggio, G., Ferguson, L., Brooks, H.L., Hyshka, E., et al. (2022). Impact of health system engagement on the health and well-being of people who use drugs: a realist review protocol. Syst Rev 11(66).
Weicker SA, Speed KA, Hyshka E, Mrochuk M, Kosteniuk B, Dong K. (2022). Emergency department care for patients who use opioids during the COVID-19 pandemic. CJEM. 24(2):123-125. doi: 10.1007/s43678-021-00229-1. Epub 2021 Nov 24.
Gehring ND, Speed KA, Launier K, O’Brien D, Campbell S, Hyshka E. (2022). The state of science on including inhalation within supervised consumption services: A scoping review of academic and grey literature. Int J Drug Policy. 102:103589.
Salvalaggio G, Dong KA, Hyshka E, McCabe C, Nixon L, Rosychuk RJ, Dmitrienko K, Krajnak J, Mrklas K, Wild TC. (2022). Impact of an addiction medicine consult team intervention in a Canadian inner city hospital on acute care utilization: a pragmatic quasi-experimental study. Subst Abuse Treat Prev Policy. 17(1):20.
Williams RJ, Belanger YD, Leonard CA, Stevens RMG, Christensen DR, El-Guebaly N, Hodgins DC, McGrath DS. (2022). Indigenous Gambling and Problem Gambling in Canada. J Gambl Stud. 38(1):67-85

2021

Jenkins E, Slemon A, Morris H, Hyshka E, Schulz P, Haines-Saah RJ. (2021). Bereaved mothers’ engagement in drug policy reform: A multisite qualitative analysis. Int J Drug Policy. 91:103011.
Lee C, Voaklander D, Minhas-Sandhu JK, Hanlon JG, Hyshka E, Dyck JRB, Eurich DT. (2021). Cohort study of medical cannabis authorization and motor vehicle crash-related healthcare visits in 2014-2017 in Ontario, Canada. Inj Epidemiol. 8(1):33.
Lee C, Lin M, Martins KJB, Dyck JRB, Klarenbach S, Richer L, Jess E, Hanlon JG, Hyshka E, Eurich DT. (2021). Opioid use in medical cannabis authorization adult patients from 2013 to 2018: Alberta, Canada. BMC Public Health. 21(1):843.
Kosteniuk B, Salvalaggio G, McNeil R, Brooks HL, Dong K, Twan S, Brouwer J, Hyshka E. (2021). “You don’t have to squirrel away in a staircase”: Patient motivations for attending a novel supervised drug consumption service in acute care. Int J Drug Policy. 96:103275.
Lee C, Lin M, Martins KJB, Dyck JRB, Klarenbach S, Richer L, Jess E, Hanlon JG, Hyshka E, Eurich DT. (2021). Opioid use in medical cannabis authorization adult patients from 2013 to 2018: Alberta, Canada. BMC Public Health. 21(1):843.
Lee C, Round JM, Klarenbach S, Hanlon JG, Hyshka E, Dyck JRB, Eurich DT. (2021). Gaps in evidence for the use of medically authorized cannabis: Ontario and Alberta, Canada. Harm Reduct J. 18(1):61.
Lee C, Round JM, Hanlon JG, Hyshka E, Dyck JRB, Eurich DT. (2021). Generalized Anxiety Disorder 7-Item (GAD-7) Scores in Medically Authorized Cannabis Patients-Ontario and Alberta, Canada. Can J Psychiatry. 7067437211043393.
Zongo A, Lee C, Dyck JRB, El-Mourad J, Hyshka E, Hanlon JG, Eurich DT. (2021). Medical cannabis authorization and the risk of cardiovascular events: a longitudinal cohort study. BMC Cardiovasc Disord. 21(1):426.
Zongo A, Lee C, El-Mourad J, Dyck JRB, Hyshka E, Hanlon JG, Eurich DT. (2021). Substance Use Disorders and Psychoactive Drug Poisoning in Medically Authorized Cannabis Patients: Longitudinal Cohort Study Can J Psychiatry.
Biggar E, Papamihali K, Leclerc P, Hyshka E, Graham B, Taylor M, Payer D, Maloney-Hall B, Buxton JA. (2021). Towards cross-Canada monitoring of the unregulated street drug supply. BMC Public Health. 2021 Sep 15;21(1):1678.
Kosteniuk B, Salvalaggio G, Wild TC, Gelberg L, Hyshka E. (2021). Perceived unmet substance use and mental health care needs of acute care patients who use drugs: A cross-sectional analysis using the Behavioral Model for Vulnerable Populations. Drug Alcohol Rev.
Eurich D, Lee C, Zongo A, Minhas-Sandhu JK, Hanlon JG, Hyshka E, Dyck J. (2021). Cohort study of medical cannabis authorisation and healthcare utilisation in 2014-2017 in Ontario, Canada. J Epidemiol Community Health. 74(3):299-304.
Morris, H., Schulz, P., Jenkins, E., Haines-Saah, R., Hyshka, E. (2021). “I’m not your reality show:” Perspectives of bereaved mothers’ engagement with the news media to advance drug policy reform. SSM – Qualitative Research in Health. 1;100011.
Morris, H., Hyshka, E., Schulz, P., Jenkins, E., Haines-Saah, R. (2021). “It’s a Bit of a Double-Edged Sword”: Motivation and Personal Impact of Bereaved Mothers’ Advocacy for Drug Policy Reform. Qualitative Health Research. 31(10);1812-22.
Wild TC, Koziel J, Anderson-Baron J, Asbridge M, Belle-Isle L, Dell C, Elliott R, Hathaway A, MacPherson D, McBride K, Pauly B, Strike C, Galovan A, Hyshka E. (2021). Public support for harm reduction: A population survey of Canadian adults. PLoS One. 16(5):e0251860.

2020

O’Keefe-Markman C, Lea KD, McCabe C, Hyshka E, Bubela T. (2020). Social values for health technology assessment in Canada: a scoping review of hepatitis C screening, diagnosis and treatment. BMC Public Health. 20(1):89. doi: 10.1186/s12889-020-8190-2.
Milaney K, Williams N, Lockerbie SL, Dutton DJ, Hyshka E. (2020). Recognizing and responding to women experiencing homelessness with gendered and trauma-informed care. BMC Public Health. 20(1):397. doi: 10.1186/s12889-020-8353-1.
Dong KA, Brouwer J, Johnston C, Hyshka E. (2020). Supervised consumption services for acute care hospital patients. CMAJ. 192(18):E476-E479. doi: 10.1503/cmaj.191365.
Round JM, Lee C, Hanlon JG, Hyshka E, Dyck JRB, Eurich DT. (2020). Changes in patient health questionnaire (PHQ-9) scores in adults with medical authorization for cannabis. BMC Public Health. 20(1):987. doi: 10.1186/s12889-020-09089-3.
Brooks HL, Husband C, Taylor M, Sherren A, Hyshka E. (2020). Supporting the full participation of people who use drugs in policy fora: Provision of a temporary, conference-based overdose prevention site. Int J Drug Policy. 84:102878. doi: 10.1016/j.drugpo.2020.102878. Epub 2020 Jul 30.
Speed KA, Gehring ND, Launier K, O’Brien D, Campbell S, Hyshka E. (2020). To what extent do supervised drug consumption services incorporate non-injection routes of administration? A systematic scoping review documenting existing facilities. Harm Reduct J. 17(1):72. doi: 10.1186/s12954-020-00414-y.
Dong KA, Brouwer J, Johnston C, Hyshka E. (2020). Supervised consumption services for acute care hospital inpatients. CMAJ. 192:E476-9. DOI: 10.1503/cmaj.191365.
Jenkins, El, Slemon, A., Morris, H., Hyshka, E., Schulz, P., Haines-Saah, R.J. (2020). Bereaved mothers’ engagement in drug policy reform: A multisite qualitative analysis. International Journal of Drug Policy. https://doi.org/10.1016/j.drugpo.2020.103011
Milaney, K., Williams, N., Lockerbie, S.L., Dutton, D.J., Hyshka, E. (2020). Recognizing and responding to women experiencing homelessness with gendered and trauma-informed care. BMC Public Health. 20, 397.
Pawliuk C, Park M, Buxton JA on behalf of the Overdose Crisis Knowledge Synthesis Working Group. (2020). Legal approaches and government policies enacted to address the overdose epidemic: A scoping review protocol. JBI Evidence Synthesis. doi: 10.11124/JBISRIR-D-19-00296.
Round JM, Lee C, Hanlon JG, Hyshka E, Dyck J, Eurich D. (2020). Changes in patient health questionnaire (PHQ-9) scores in adults with medical authorization for cannabis. BMC Public Health. 20:987. DOI: 1186/s12889-020-09089-3.

2019

Brooks HL, O’Brien D, Salvalaggio G, Dong K, Hyshka E. (2019). Uptake into a bedside needle and syringe program for acute care inpatients who inject drugs. Drug & Alcohol Review.
Eurich D, Lee C, Zongo A, Minhas-Sandhu JK, Hanlon JG, Hyshka E, Dyck J. (2019). Cohort study of medical cannabis authorisation and healthcare utilisation in 2014-2017 in Ontario, Canada. J Epidemiol Community Health. pii: jech-2019-212438.
Hyshka, E., Morris, H., Anderson-Baron, J., Nixon, L., Dong, K., & Salvalaggio, G. (2019). Patient perspectives on a harm reduction-oriented addiction medicine consultation team implemented in a large acute care hospital. Drug and Alcohol Dependence. 204, 107523.
Hyshka, E., Anderson-Baron, L., Pugh, A., Belle-Isle, L., Hathaway, A., Pauly, B., Strike, C., Asbridge, M., Dell, C., McBride, K., Tupper, K., Wild, C. (2019). Principles, practice, and policy vacuums: Policy actor views on provincial/territorial harm reduction policy in Canada. International Journal of Drug Policy. 71, 142-149.
Lee C, Voaklander D, Minhas-Sandhu JK, Dyck J, Hanlon JG, Hyshka E, Eurich DT. (2019). Cohort study of medical cannabis authorizations and motor vehicle accident-related healthcare visits in 2014-2017 in Ontario, Canada. Revision requested. Injury Prevention.
Morris H, Hagen L, Hyshka E, Francescutti LH. (2019). Empowering Students and Influencing Policy Change Through Experiential Public Health Advocacy Education. J Nurs Educ. 58(12), 698-703.
O’Brien, D. C., Dabbs, D., Dong, K., Veugelers, P. J., & Hyshka, E. (2019). Patient characteristics associated with being offered take home naloxone in a busy, urban emergency department: A retrospective chart review. BMC Health Services Research. 19(1), 1-12.
Watson TM, Valleriani J, Hyshka E, Rueda S. (2019). Cannabis legalization in the provinces and territories: Missing opportunities to effectively educate youth? Canadian Journal of Public Health. 110(4), 472-475.
Watson TM, Hyshka E, Bonato S, Rueda S. (2019). Early-stage cannabis regulatory policy planning across Canada’s four largest provinces: A descriptive overview. Substance Use & Misuse. 54(10), 1691-1704.
Wild, C., Kozie, J., Anderson-Barron, J., Hathaway, J., McCurdy, A., Xu, X., . . . Hyshka, E. (2019). Media coverage of harm reduction, 2000-2016: A content analysis of tone, topics, and interventions in Canadian print news. Drug and Alcohol Dependence. 205, 107599.
Yakovenko, I., Hyshka, E., Tyrrell, L., & Wild, T. (2019). Willingness to participate in hepatitis C vaccine trials among socially marginalized people who use drugs. Journal of Substance Abuse Treatment. 101, 67-71.

2018

Brooks HL, Kassam S, Salvalaggio G, Hyshka E. (2018). Implementing managed alcohol programs in hospital settings: A review of academic and grey literature. Drug Alcohol Rev. 37 Suppl 1:S145-S155.

2017

Hyshka E., Anderson J.T., Wild T.C. (2017). Perceived unmet need and barriers to care amongst street-involved people who use illicit drugs. Drug and Alcohol Review. 36(3), 295-304.
Hyshka, E., Anderson-Baron,J., Karekezi, K., Belle-Isle, L., Elliott, R., Pauly, B., Strike, C., Asbridge, M., Dell, C., McBride, K., Hathaway, A., & Wild, T.C. (2017). Harm reduction in name but not substance: A comparative analysis of Canadian provincial and territorial policy frameworks. Harm Reduction Journal, 14,50.
Hyshka, E., Karekezi, K., Tan, B., Slater, L.G., Jahrig, J., & Wild, T.C. (2017). The role of consumer perspectives in estimating population need for substance use services: A scoping review. BMC Health Services Research, 36(3),295-304.
Wild, T., Pauly, B., Belle-Isle, L., Cavalieri, W., Elliott, R., Strike, C., Tupper, K., Hathaway, A., Dell, C., MacPherson, D., Sinclair, C., Karekezi, K., Tan, B., Hyshka, E. (2017) Canadian Harm Reduction Policies: A Comparative Content Analysis of Provincial and Territorial Documents, 2000-2015”. International Journal of Drug Policy. 45, 9-17.

2016

Kirst M, Kolar K, Chaiton M, Schwartz R, Emerson B, Hyshka E, Jesseman R, Lucas P, Solomon R, Thomas G. (2016). A common public health-oriented policy framework for cannabis, alcohol and tobacco in Canada? Can J Public Health. 106(8):e474-6.
Salvalaggio, G., Dong, K.A., Hyshka, E., Nixon, L., Lavergne, K., Nicol, J., Louis, M., Lockerbie, S., Bristowe, M., Leske, J., Rosychuk, R.J., Mrklas, K., Surood, S., & Wild, T.C. (2016). Enhanced multidisciplinary care for inner city patients with high acute care use: Study protocol. Canadian Journal of Addiction. 7(3),34-41.

2015 and earlier

Hyshka E, Bubela T, Wild TC. (2013). Prospects for scaling-up supervised injection facilities in Canada: the role of evidence in legal and political decision-making. Addiction. 108(3), 468-76.
Kerr T, Small W, Hyshka E, Maher L, Shannon K. (2013). ‘It’s more about the heroin’: injection drug users’ response to an overdose warning campaign in a Canadian setting. Addiction. 108(7), 1270-6.
Hyshka E, Strathdee S, Wood E, Kerr T. (2012). Needle exchange and the HIV epidemic in Vancouver: lessons learned from 15 years of research. Int J Drug Policy. 23(4), 261-70.
Hyshka E, Butler-McPhee J, Elliott R, Wood E, Kerr T. (2012). Canada moving backwards on illegal drugs. Can J Public Health. 103(2), 125-7.
Hyshka E, Erickson PG, Hathaway A. (2011). The time for marijuana decriminalization has come again . . . and again. Criminal Law Bulletin. 47(2):258-275.
Erickson PG, Hyshka E. (2010). Four decades of cannabis criminals in Canada 1970-2010. Amsterdam Law Forum. 2(4):14.
Hathaway A, Hyshka E, Erickson PG, Asbridge M, Brochu S, Cousineau MM, Duff C, Marsh D. (2010). Whither RDS? An investigation of Respondent Driven Sampling as a method of recruiting mainstream marijuana users. Harm Reduction Journal. 7:15.
Hyshka E. (2009). The Saga Continues: Canadian Legislative Attempts to Reform Cannabis Law in the Twenty-First Century. Canadian Journal of Criminology and Criminal Justice. 51(1), 73–91.
Hyshka, E. (2009). Turning failure into success: what does the case of Western Australia tell us about Canadian cannabis policy-making? Policy Studies. 30(5), 513–531.
Kerr T, Small W, Hyshka E, Maher L, Shannon K. (2013). ‘It’s more about the heroin’: injection drug users’ response to an overdose warning campaign in a Canadian setting. Addiction. 108(7), 1270-6.